Profile
Thomas L.
Feldman has been President and Chief Business Officer of CoTherix, Inc. since August 2004.
He joined CoTherix in December 2003 as Executive Vice President and Chief Commercial Officer.
Prior to joining CoTherix, Mr. Feldman was Acting Vice President of Sales and Marketing for Genesoft Pharmaceuticals, Inc. from April 2003 to December 2003.
Previously, he was Vice President of Sales and Marketing for Scios, Inc. from January 1995 to December 2002, National Sales Manager of Ortho Pharmaceutical Corporation from 1993 to 1994.
Mr. Feldman has held various sales and marketing positions at Johnson & Johnson and McNeil Pharmaceutical.
He received a BS degree in Speech and Business from North Dakota State University.
Former positions of Thomas L. Feldman
| Companies | Position | End |
|---|---|---|
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | President | 31/01/2007 |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Chief Executive Officer | - |
Training of Thomas L. Feldman
| North Dakota State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas L. Feldman